Insider Ownership Filing for Dimitris Voliotis

This filing details the ownership of Radiopharm Theranostics Ltd (RADX) by Dimitris Voliotis, Chief Medical Officer. The document, a Form 3, reports the initial beneficial ownership of securities. Voliotis holds options to purchase ordinary shares, with exercise prices in Australian dollars. Specifically, there are three sets of options: one set exercisable starting July 1, 2026, another starting July 1, 2027, and a third starting July 1, 2028. All these options expire on July 1, 2030. The number of shares underlying these options are 7,657,333 for the first two sets and 7,657,334 for the third set. The exercise price for all options is AUD 0.025. The filing also explicitly states that there are no non-derivative securities beneficially owned by Voliotis and that all exercise prices are in Australian dollars.